ARCHIVES

In Brief: Lasagna Committee Report Finalized; Robinson Replaces Schmidt On MSK Boards

This article is from The Cancer Letter archive.

Vol. 16 No. 28 | July 13, 1990

Download PDF Visit The Full Archive

Related Articles

NCI To Support 39 Summer Students With Gift Money

February 8, 1985

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Support Available For Studies Abroad

August 12, 1983

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

Study Finds No Link Between Tumor Grade and Relapse Risk

February 25, 2011